If you have signs or symptoms that worry you, start by seeing your family doctor or a general practitioner.
If your doctor suspects you may have a problem with your prostate, you may be referred to a urinary tract specialist (urologist). If you're diagnosed with prostate cancer, you may be referred to a cancer specialist (oncologist) or a specialist who uses radiation therapy to treat cancer (radiation oncologist).
Because appointments can be brief, and because there's often a lot of ground to cover, it's a good idea to be prepared. Here's some information to help you get ready and what to expect from your doctor.
What you can do
- Be aware of any pre-appointment restrictions. At the time you make the appointment, be sure to ask if there's anything you need to do in advance, such as restrict your diet.
- Write down any symptoms you're experiencing, including any that may seem unrelated to the reason for which you scheduled the appointment.
- Write down key personal information, including any major stresses or recent life changes.
- Make a list of all medications, vitamins or supplements that you're taking.
- Consider taking a family member or friend along. Sometimes it can be difficult to remember all the information provided during an appointment. Someone who accompanies you may remember something that you missed or forgot.
- Write down questions to ask your doctor.
Your time with your doctor is limited, so preparing a list of questions can help you make the most of your time together. List your questions from most important to least important in case time runs out. For prostate cancer, some basic questions to ask your doctor include:
- Do I have prostate cancer?
- How large is my prostate cancer?
- Has my prostate cancer spread beyond my prostate?
- What's my Gleason score?
- What's my prostate-specific antigen (PSA) level?
- Will I need more tests?
- What are my treatment options?
- Is there one treatment option you think is best for me?
- Do I need cancer treatment right away, or is it possible to wait and see if the cancer grows?
- What are the potential side effects of each treatment?
- What is the chance that my prostate cancer will be cured with treatment?
- If you had a friend or family member in my situation, what would you recommend?
- Should I see a specialist? What will that cost, and will my insurance cover it?
- Are there brochures or other printed material that I can take with me? What websites do you recommend?
In addition to the questions that you've prepared to ask your doctor, don't hesitate to ask other questions during your appointment.
What to expect from your doctor
Your doctor is likely to ask you a number of questions. Being ready to answer them may allow more time later to cover other points you want to address. Your doctor may ask:
- When did you first begin experiencing symptoms?
- Have your symptoms been continuous or occasional?
- How severe are your symptoms?
- What, if anything, seems to improve your symptoms?
- What, if anything, appears to worsen your symptoms?
Aug. 12, 2017
- Prostate cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Jan. 21, 2017.
- Wein AJ, et al., eds. Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. http://wwwclinicalkey.com. Accessed Feb. 21, 2017.
- Gunderson LL, et al. Prostate Cancer. In:Clinical Radiation Oncology. 4th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clincalkey.com. Accessed Feb. 20, 2017.
- What you need to know about prostate cancer. National Cancer Institute. http://www.cancer.gov/publications/patient-education/wyntk-prostate-cancer. Accessed Feb. 8, 2017.
- Niederhuber JE, et al., eds. Prostate cancer. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed Jan. 21, 2017.
- Distress management. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Feb. 20, 2017.
- Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. October 24, 2016.
- Smith RA, et al. Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians. 2015;65:30.
- Prostate cancer prevention (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/prevention/prostate/healthprofessional. Accessed Feb. 20, 2017.
- Castle EP (expert opinion). Mayo Clinic, Phoenix/Scottsdale, Ariz. April 12, 2017.
- Choline C-11 injection (prescribing information). Rochester, Minn. Mayo Clinic PET Radiochemistry Facility; 2012. http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/203155Orig1s000ltr.pdf. Accessed Feb. 22, 2017.
- Vourganti S. et al. MR/US fusion technology: What makes it tick? Current Urology Reports. 2017;18:20.
- Rong N, et al. Clinically available RNA profiling tests of prostate tumors: utility and comparison. Asian Journal of Andrology. 2016;18:575.
- Conrad CA, et al. Clinically available RNA profiling tests of prostate tumors: Utility and comparison. Asian Journal of Andrology. 2016;18:505.
- Koboldt DC, et al. Rare variation in TET2 is associated with clinically relevant prostate carcinoma in African Americans. Cancer Epidemiology, Biomarkers & Prevention. 2016;25:11.
- Gettman MT, et al. Current status of robotics in urologic laparoscopy. European Urology. 2003;43:106.
- Krambeck AE, et al. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques. BJU International. 2008;103;448.
- Ashfaq A, et al. Incidence and outcomes of ventral hernia repair after robotic retropubic prostatectomy: A retrospective cohort of 570 consecutive cases. International Journal of Surgery. 2017;38:74.
- Alshalalfa1 A, et al. Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: Exploratory analysis from 12,076 patients. Oncotarget. In press. Accessed April 12, 2017.
- Kaushik D, et al. Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer. International Brazilian Journal of Urology. 2016;42:1091.
- Moris L, et al. Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection. Frontiers in Surgery. 2016;3:65.
- Leibovich BC (expert opinion). Mayo Clinic, Rochester, Minn. June 2, 2017.